Association of soluble receptor for advanced glycation end-products (sRAGE) serum on COVID-19 severity: A cross-sectional study
Background Coronavirus disease 2019 (COVID-19) is a new health problem discovered in 2019 thus requires biomarkers that can detect early tissue damage. Soluble receptor for advanced glycation end-products (sRAGE) is a biomarker that can be used to identify early lung damage. Objective Analyzing...
Saved in:
Similar Items
-
Association of soluble receptor for advanced glycation end-products (sRAGE) serum on COVID-19 severity: A cross-sectional study
by: Noor Ramadany Saputra, Gusti, et al. -
Association of serum KL-6 levels on COVID-19 severity: A cross-sectional study design with purposive sampling
by: Dhadhari Suryananda, Titah, et al. -
Capillary Lactate Level in Non-Severe and Severe CommunityAcquired Pneumonia Patients
by: Yudhawati, Resti, et al. -
Correlation of serum interleukin-6 level and pneumonia severity index score in patient with community-acquired pneumonia
by: Yudhawati Meliana, Resti, et al.
Published: (2021) -
Biological Therapy for Asthma
by: Meliana, Resti Yudhawati, et al.
Published: (2021)